生长激素缺乏-话题@MedSci

#生长激素缺乏#

15篇内容 | 1310人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1407473, encodeId=5f01140e4731d, content=<a href='/topic/show?id=a79569632f4' target=_blank style='color:#2F92EE;'>#生长激素缺乏#</a>, objectTitle=针对生长激素缺乏症（GHD），FDA为Somatrogon发出了完整的回复信（CRL）, objectType=article, longId=294566, objectId=8e112945669d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e112945669d, replyNumber=0, likeNumber=122, createdTime=2022-01-25, rootId=0, userName=lidong41, userId=a3fa2654160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e112945669d, moduleTitle=针对生长激素缺乏症（GHD），FDA为Somatrogon发出了完整的回复信（CRL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e112945669d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407472, encodeId=be17140e472ce, content=<a href='/topic/show?id=a79569632f4' target=_blank style='color:#2F92EE;'>#生长激素缺乏#</a>, objectTitle=儿童生长激素缺乏的诊断和治疗, objectType=article, longId=220129, objectId=9f88220129f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f88220129f5, replyNumber=0, likeNumber=76, createdTime=2021-11-12, rootId=0, userName=lidong41, userId=a3fa2654160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f88220129f5, moduleTitle=儿童生长激素缺乏的诊断和治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f88220129f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407471, encodeId=5190140e471fb, content=<a href='/topic/show?id=a79569632f4' target=_blank style='color:#2F92EE;'>#生长激素缺乏#</a>, objectTitle=EMA接受Somatrogon的市场营销申请，以治疗生长激素缺乏症患儿, objectType=article, longId=207703, objectId=22ff20e70355, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22ff20e70355, replyNumber=0, likeNumber=80, createdTime=2021-03-01, rootId=0, userName=lidong41, userId=a3fa2654160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22ff20e70355, moduleTitle=EMA接受Somatrogon的市场营销申请，以治疗生长激素缺乏症患儿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22ff20e70355)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407470, encodeId=f6f6140e4706e, content=<a href='/topic/show?id=a79569632f4' target=_blank style='color:#2F92EE;'>#生长激素缺乏#</a>, objectTitle=欧洲监管机构对Sogroya（somapacitan）治疗成人生长激素缺乏症持积极意见, objectType=article, longId=206440, objectId=319320644031, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=319320644031, replyNumber=0, likeNumber=64, createdTime=2021-02-01, rootId=0, userName=lidong41, userId=a3fa2654160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=319320644031, moduleTitle=欧洲监管机构对Sogroya（somapacitan）治疗成人生长激素缺乏症持积极意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=319320644031)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407469, encodeId=e062140e4691c, content=<a href='/topic/show?id=a79569632f4' target=_blank style='color:#2F92EE;'>#生长激素缺乏#</a>, objectTitle=长效生长激素Somatrogon治疗生长激素缺乏症儿童，日本3期临床成功, objectType=article, longId=195624, objectId=fdb21956248b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdb21956248b, replyNumber=0, likeNumber=110, createdTime=2020-06-12, rootId=0, userName=lidong41, userId=a3fa2654160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdb21956248b, moduleTitle=长效生长激素Somatrogon治疗生长激素缺乏症儿童，日本3期临床成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdb21956248b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407468, encodeId=de20140e4683c, content=<a href='/topic/show?id=a79569632f4' target=_blank style='color:#2F92EE;'>#生长激素缺乏#</a>, objectTitle=OPKO和辉瑞宣布长效化生长激素GENOTROPIN治疗生长激素缺乏症儿童的3期临床成功, objectType=article, longId=181709, objectId=aafc181e09cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aafc181e09cb, replyNumber=0, likeNumber=115, createdTime=2019-10-23, rootId=0, userName=lidong41, userId=a3fa2654160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aafc181e09cb, moduleTitle=OPKO和辉瑞宣布长效化生长激素GENOTROPIN治疗生长激素缺乏症儿童的3期临床成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aafc181e09cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407467, encodeId=37b4140e46721, content=<a href='/topic/show?id=a79569632f4' target=_blank style='color:#2F92EE;'>#生长激素缺乏#</a>, objectTitle=每周一次的somapacitan治疗生长激素缺乏症儿童，效果与每日一次的生长激素相当, objectType=article, longId=179928, objectId=4a451e992828, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a451e992828, replyNumber=0, likeNumber=70, createdTime=2019-09-25, rootId=0, userName=lidong41, userId=a3fa2654160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a451e992828, moduleTitle=每周一次的somapacitan治疗生长激素缺乏症儿童，效果与每日一次的生长激素相当, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a451e992828)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407466, encodeId=bcbf140e466b1, content=<a href='/topic/show?id=a79569632f4' target=_blank style='color:#2F92EE;'>#生长激素缺乏#</a>, objectTitle=TransCon生长激素治疗儿童生长激素缺乏症三期临床研究核心结果公布, objectType=article, longId=161852, objectId=274016185262, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=274016185262, replyNumber=0, likeNumber=65, createdTime=2019-03-09, rootId=0, userName=lidong41, userId=a3fa2654160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=274016185262, moduleTitle=TransCon生长激素治疗儿童生长激素缺乏症三期临床研究核心结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=274016185262)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407465, encodeId=29a0140e4659b, content=<a href='/topic/show?id=a79569632f4' target=_blank style='color:#2F92EE;'>#生长激素缺乏#</a>, objectTitle=J Periodontol：单纯性生长激素缺乏症的牙周免疫学和微生物分析, objectType=article, longId=153658, objectId=2559153658bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2559153658bb, replyNumber=0, likeNumber=60, createdTime=2018-11-17, rootId=0, userName=lidong41, userId=a3fa2654160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2559153658bb, moduleTitle=J Periodontol：单纯性生长激素缺乏症的牙周免疫学和微生物分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2559153658bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407464, encodeId=ab95140e4648f, content=<a href='/topic/show?id=a79569632f4' target=_blank style='color:#2F92EE;'>#生长激素缺乏#</a>, objectTitle=OPKO公司完成生长激素缺乏患儿（hGH-CTP）的Somatrogon全球III期研究的入组, objectType=article, longId=145945, objectId=022514594548, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=022514594548, replyNumber=0, likeNumber=57, createdTime=2018-08-07, rootId=0, userName=lidong41, userId=a3fa2654160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=022514594548, moduleTitle=OPKO公司完成生长激素缺乏患儿（hGH-CTP）的Somatrogon全球III期研究的入组, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=022514594548)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407463, encodeId=ac20140e46352, content=<a href='/topic/show?id=a79569632f4' target=_blank style='color:#2F92EE;'>#生长激素缺乏#</a>, objectTitle=FDA批准年度第44款新药用于生长激素缺乏症, objectType=article, longId=124355, objectId=2f411243553a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f411243553a, replyNumber=0, likeNumber=72, createdTime=2017-12-24, rootId=0, userName=lidong41, userId=a3fa2654160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f411243553a, moduleTitle=FDA批准年度第44款新药用于生长激素缺乏症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f411243553a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407462, encodeId=3ccf140e46226, content=<a href='/topic/show?id=a79569632f4' target=_blank style='color:#2F92EE;'>#生长激素缺乏#</a>, objectTitle=2016 PES指南：生长激素缺乏，特发性矮小症和原发性胰岛素样生长因子缺乏儿童和青少年应用生长激素和胰岛素样生长因子1治疗, objectType=article, longId=86375, objectId=68b5863e5d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68b5863e5d2, replyNumber=0, likeNumber=53, createdTime=2017-01-03, rootId=0, userName=lidong41, userId=a3fa2654160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68b5863e5d2, moduleTitle=2016 PES指南：生长激素缺乏，特发性矮小症和原发性胰岛素样生长因子缺乏儿童和青少年应用生长激素和胰岛素样生长因子1治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68b5863e5d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407461, encodeId=4354140e4614d, content=<a href='/topic/show?id=a79569632f4' target=_blank style='color:#2F92EE;'>#生长激素缺乏#</a>, objectTitle=成人生长激素缺乏症诊治指南解读, objectType=article, longId=59428, objectId=698659428d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=698659428d2, replyNumber=0, likeNumber=58, createdTime=2015-11-26, rootId=0, userName=lidong41, userId=a3fa2654160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=698659428d2, moduleTitle=成人生长激素缺乏症诊治指南解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=698659428d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407460, encodeId=5f5c140e460fc, content=<a href='/topic/show?id=a79569632f4' target=_blank style='color:#2F92EE;'>#生长激素缺乏#</a>, objectTitle=J Clin Endocrinol Metab：成人生长激素缺乏症无氧代谢能力受到损害, objectType=article, longId=47413, objectId=032a4e4132a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=032a4e4132a, replyNumber=0, likeNumber=73, createdTime=2015-02-26, rootId=0, userName=lidong41, userId=a3fa2654160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=032a4e4132a, moduleTitle=J Clin Endocrinol Metab：成人生长激素缺乏症无氧代谢能力受到损害, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=032a4e4132a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1407459, encodeId=a550140e459a0, content=<a href='/topic/show?id=a79569632f4' target=_blank style='color:#2F92EE;'>#生长激素缺乏#</a>, objectTitle=Aeterna公司公布成人生长激素缺乏症治疗药物AEZS-130 3期临床结果, objectType=article, longId=7442, objectId=2e04e44244, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e04e44244, replyNumber=0, likeNumber=64, createdTime=2012-06-30, rootId=0, userName=lidong41, userId=a3fa2654160, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e04e44244, moduleTitle=Aeterna公司公布成人生长激素缺乏症治疗药物AEZS-130 3期临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e04e44244)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生长激素缺乏

2020-05-29

lidong41 (审核中...)

前往app查看评论内容

#生长激素缺乏#

针对生长激素缺乏症（GHD），FDA为Somatrogon发出了完整的回复信（CRL）

2022-01-25

lidong41 (审核中...)

前往app查看评论内容

#生长激素缺乏#

儿童生长激素缺乏的诊断和治疗

2021-11-12

lidong41 (审核中...)

前往app查看评论内容

#生长激素缺乏#

EMA接受Somatrogon的市场营销申请，以治疗生长激素缺乏症患儿

2021-03-01

lidong41 (审核中...)

前往app查看评论内容

#生长激素缺乏#

欧洲监管机构对Sogroya（somapacitan）治疗成人生长激素缺乏症持积极意见

2021-02-01

lidong41 (审核中...)

前往app查看评论内容

#生长激素缺乏#

长效生长激素Somatrogon治疗生长激素缺乏症儿童，日本3期临床成功

2020-06-12

lidong41 (审核中...)

前往app查看评论内容

#生长激素缺乏#

OPKO和辉瑞宣布长效化生长激素GENOTROPIN治疗生长激素缺乏症儿童的3期临床成功

2019-10-23

lidong41 (审核中...)

前往app查看评论内容

#生长激素缺乏#

每周一次的somapacitan治疗生长激素缺乏症儿童，效果与每日一次的生长激素相当

2019-09-25

lidong41 (审核中...)

前往app查看评论内容

#生长激素缺乏#

TransCon生长激素治疗儿童生长激素缺乏症三期临床研究核心结果公布

2019-03-09

lidong41 (审核中...)

前往app查看评论内容

#生长激素缺乏#

J Periodontol：单纯性生长激素缺乏症的牙周免疫学和微生物分析

2018-11-17

lidong41 (审核中...)

前往app查看评论内容

#生长激素缺乏#

OPKO公司完成生长激素缺乏患儿（hGH-CTP）的Somatrogon全球III期研究的入组

2018-08-07

lidong41 (审核中...)

前往app查看评论内容

#生长激素缺乏#

FDA批准年度第44款新药用于生长激素缺乏症

2017-12-24

lidong41 (审核中...)

前往app查看评论内容

#生长激素缺乏#

2016 PES指南：生长激素缺乏，特发性矮小症和原发性胰岛素样生长因子缺乏儿童和青少年应用生长激素和胰岛素样生长因子1治疗

2017-01-03

lidong41 (审核中...)

前往app查看评论内容

#生长激素缺乏#

成人生长激素缺乏症诊治指南解读

2015-11-26

lidong41 (审核中...)

前往app查看评论内容

#生长激素缺乏#

J Clin Endocrinol Metab：成人生长激素缺乏症无氧代谢能力受到损害

2015-02-26

lidong41 (审核中...)

前往app查看评论内容

#生长激素缺乏#

Aeterna公司公布成人生长激素缺乏症治疗药物AEZS-130 3期临床结果

2012-06-30

科室
- - 订阅+
  - 更多科室
工具
服务